Stanford Biotechnology Group

Stanford Biotech Group Podcast

Science EN ↓ 4 Folgen

The Stanford Biotech Group Podcast is your front-row seat to the people shaping the future of the life sciences. Run by Stanford graduate and professional students across PhD, MD, MBA, and MS programs, we sit down with the scientists, founders, and investors driving biotech forward. Let's pulling back the curtain on the breakthroughs, bets, and big ideas redefining medicine!

Autor

Stanford Biotechnology Group

Kategorie

Science

Neueste Folge

17. Nov 2026

Wo hören?

Podcasts in der App Replaio Radio Bald verfügbar

Podcasts kommen bald in die App. Installiere sie jetzt und erlebe als Erster einen ganz neuen Blick auf Podcasts

Bei Google Play herunterladen Kostenlos installieren Android 10 Mio.+ Downloads · Bewertung 4,7+ iOS bald

Folgen

Who Owns the Discovery? Biotech Patents and AI with Julia Minitti 17.11.2026

What should you think about before sharing a discovery in a preprint, on a conference poster, or with a chatbot? Host Afi Tagnedji sits down with Julia Minitti, a Wilson Sonsini patent partner and former medicinal chemist, to talk about when to file a patent, what investors look for in a biotech startup’s intellectual property, and who gets credit when AI helps design a drug. Julia also shares wha...

The Future of Farming Is Biotech 02.11.2026

In this episode of the Stanford Biotech Group Podcast, our Co-VP of Communications, Mikaela Ribi, sits down with Tim Schnabel, founder and CEO of Switch Bioworks, a Stanford spinout engineering microbes to produce sustainable nitrogen fertilizer. Together, we explore his journey from PhD research to entrepreneurship, the challenges of translating scientific discoveries into practical solutions, an...

World-Class Science. But Where Are Australia’s Biotechs? 21.10.2026

Our guest is Dr. Bob Soh, a partner at Brandon Capital, Australia’s biggest life sciences venture capital firm. Bob talks with Rui Yip about why Australia’s strong research base hasn’t produced a bigger biotech industry, and why overseas biotechs often run their Phase 1 trials here. They also cover how veterans of big pharma are helping launch new companies, how the local pool of biotech venture c...

Inside TwoStep: From the Bench to the Term Sheet, and Now, the Clinic 13.05.2026

Caitlyn Miller, CEO and co-founder of TwoStep Therapeutics, joins the SBG podcast to discuss her Series A biotech's five-target peptide platform for solid tumors, the path from Stanford PhD to funded company, and what no one tells you about founding.

Höre den Podcast Stanford Biotech Group Podcast in Replaio

Radio und Podcasts in einer App - kostenlos und ohne Anmeldung. Installiere sie noch heute und verpasse den Start nicht

Bei Google Play herunterladen

Replaio ist kein Herausgeber von Podcasts; die Namen der Sendungen, Cover und Audioinhalte gehören ihren Autoren und werden über öffentliche RSS-Feeds verbreitet